Symbiotix, Inc. has been acquired by Havas Health, Inc.
November 2015 — Symbiotix, a US medical communications and marketing agency, has been sold to Paris-based Havas and has become part of Havas Health, a leading, global healthcare marketing network. Financial details were not disclosed. Symbiotix leverages science and strategy to engage physicians and other healthcare professionals (HCPs).
Symbiotix was founded in 1998 by Tim and Jo Ann Rice in Lexington, Kentucky. The company will continue to operate from Lexington, with the Rices serving as CEO and COO respectively. Approximately 40 percent of Symbiotix’s staff are based in field offices near major clients in California, Illinois, Pennsylvania and the New York Tristate area.
Havas Health owns and operates health and wellness communication networks. The company offers advertising, public relations, event promotion, digital marketing, direct-to-patient, consulting, DTC/DTP and B2B services. It also engages in educating medical and consumer communities about disease and treatment awareness, and provides strategic consultation for optimizing communications to HCPs, payers, patients and consumers. The addition of Symbiotix to its portfolio will help Havas Health meet the demand for enhanced medical communications.
Our role in the transaction
Oaklins' media specialist team in New York was the exclusive financial advisor to Symbiotix in this transaction.
Talk to the deal team
Reed Phillips
Oaklins DeSilva+Phillips
Related deals
DIGMATIX has entered Romania through the acquisition of Elian Solutions
DIGMATIX, one of the largest providers of Microsoft Business Applications solutions in the region, has acquired Elian Solutions, a Romanian Microsoft Dynamics 365 partner, together with its subsidiary Elian Development Systems. Through the acquisition, DIGMATIX expands its operations into Romania and strengthens its position as a regional leader in the implementation and development of Microsoft Business Applications solutions. The acquisition was financed by an investment from DIGMATIX’s majority shareholder, Baltic private equity fund Livonia Partners, together with financing provided by SEB Bank.
Learn moreHeka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn moreEducbank has been acquired by Cogna
Cogna Educação, through its subsidiary Somos Sistemas de Ensino, has acquired an additional 47% stake in Educbank for approximately US$8.9 million, increasing its ownership from 43% to 90% and consolidating control of the platform. The transaction expands Cogna’s presence beyond its traditional enrollment-driven education business into the financial infrastructure that underpins school tuition collection.
Learn more